全文获取类型
收费全文 | 28045篇 |
免费 | 2316篇 |
国内免费 | 920篇 |
专业分类
耳鼻咽喉 | 117篇 |
儿科学 | 468篇 |
妇产科学 | 432篇 |
基础医学 | 1963篇 |
口腔科学 | 299篇 |
临床医学 | 2996篇 |
内科学 | 6401篇 |
皮肤病学 | 443篇 |
神经病学 | 1508篇 |
特种医学 | 332篇 |
外国民族医学 | 6篇 |
外科学 | 2345篇 |
综合类 | 3030篇 |
现状与发展 | 14篇 |
预防医学 | 607篇 |
眼科学 | 474篇 |
药学 | 5824篇 |
13篇 | |
中国医学 | 693篇 |
肿瘤学 | 3316篇 |
出版年
2024年 | 50篇 |
2023年 | 562篇 |
2022年 | 825篇 |
2021年 | 1348篇 |
2020年 | 1168篇 |
2019年 | 1063篇 |
2018年 | 1057篇 |
2017年 | 1058篇 |
2016年 | 961篇 |
2015年 | 1060篇 |
2014年 | 1695篇 |
2013年 | 2604篇 |
2012年 | 1476篇 |
2011年 | 1703篇 |
2010年 | 1356篇 |
2009年 | 1352篇 |
2008年 | 1444篇 |
2007年 | 1341篇 |
2006年 | 1272篇 |
2005年 | 1147篇 |
2004年 | 928篇 |
2003年 | 820篇 |
2002年 | 649篇 |
2001年 | 535篇 |
2000年 | 416篇 |
1999年 | 382篇 |
1998年 | 328篇 |
1997年 | 318篇 |
1996年 | 257篇 |
1995年 | 256篇 |
1994年 | 199篇 |
1993年 | 176篇 |
1992年 | 145篇 |
1991年 | 163篇 |
1990年 | 153篇 |
1989年 | 119篇 |
1988年 | 105篇 |
1987年 | 63篇 |
1986年 | 77篇 |
1985年 | 107篇 |
1984年 | 99篇 |
1983年 | 72篇 |
1982年 | 73篇 |
1981年 | 74篇 |
1980年 | 50篇 |
1979年 | 37篇 |
1978年 | 42篇 |
1977年 | 25篇 |
1976年 | 21篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
Introduction
Residual procoagulants has been suggested to play an important role in the occurrence of thromboembolic events with intravenous immunoglobulin.Objective
This study investigated the predominant plasma proteases in 81 intravenous immunoglobulin lots from 11 Chinese manufacturers to examine the procoagulants of these human therapeutic intravenous immunoglobulin products.Methods
In one-stage clotting assays, the procoagulant activities of factors II, VII, IX, X, XI, and XII were quantified. Non-activated partial thromboplastin time and a modified thrombin generation test served as global and activated coagulation factor XI specific clotting assays, respectively.Results
The coagulation factor clotting activities of the 78 intravenous immunoglobulin lots were below the detection limit of the assays. The time to peak of thrombin generation using a thrombin generation test was longer than 35 min. The relevant amount of activated coagulation factor XI was below 0.37 nM. Non-activated partial thromboplastin time was greater than 203 s, except for the three pilot samples of manufacturer B in which we observed 0.48 to 0.09 IU/mL factor XI lever, 20 to 26 min for the time to peak of thrombin generation, 0.54 to 37.99 nM activated coagulation factor XI, and 155 to 182 s for non-activated partial thromboplastin time.Conclusions
The three intravenous immunoglobulin lots from manufacturer B showed significant procoagulant potential. Further study is required to determine whether a program for activated coagulation factor XI determination in intravenous immunoglobulin products should be launched in China. 相似文献992.
Christine L. Hvas Christian Fenger-Eriksen Søren Høyer Benny Sørensen Else Tønnesen 《Thrombosis research》2013
Background
Cerebral injury and brain death is associated with apparent hypercoagulation and poor organ outcome. This experimental study challenges the hypotheses that i) brain death causes hypercoagulation and microvascular thrombosis and that ii) neutralizing systemic tissue factor (TF) by in vitro addition of a TF inhibitor (recombinant active site-inhibited factor VIIa (ASIS)) can reverse the hypercoagulable profile.Methods
Using a validated pig model of intracranial hemorrhage and brain death, 20 pigs were randomized to either control or brain death. The primary endpoints were coagulation parameters measured with whole blood thromboelastometry (ROTEM), thrombin generation and a porcine TF-sensitive plasma clotting time assay. In vitro spiking experiments with ASIS were performed in parallel with the latter two assessments. The kidneys were examined histologically for microvascular thromboses.Results
Brain death induced hypercoagulation, as demonstrated with ROTEM, thrombin generation, and reduced TF-sensitive plasma clotting time. In vitro inhibition of TF with ASIS did not reverse the hypercoagulation. No microvascular thromboses were found in the kidneys.Conclusion
Brain death causes hypercoagulation; however, inhibition of TF does not reverse the coagulopathy. Thus, TF release does not seem to be the primary cause of this hypercoagulation. Minor changes in the levels of protein C suggest that the protein C pathway may be linked to the observed coagulopathy. 相似文献993.
Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis
Saša Anžej Doma Maja VučnikMojca Božič Mijovski Polona PeternelMojca Stegnar 《Thrombosis research》2013
Introduction
In women who suffer venous thrombosis (VT) during oral contraceptive (OC) use, a transient risk factor (OC) is removed during the acute event, while most co-existing forms of thrombophilia persist and presumably continue to maintain hypercoagulability. The aim of this study was to establish if hypercoagulability persists long after OC-related VT and if it could be attributed to thrombophilia.Materials and Methods
60 women (age 33.0 ± 8.5 years) were investigated 5 – 64 (median 33) months after OC-related VT (patients) and compared to 63 apparently healthy women (controls). All women were tested for thrombophilia, activated partial thromboplastin time (APTT), fibrinogen, D-dimer, P-selectin and C-reactive protein. Thrombin generation was measured by Technothrombin® TGA assay. Overall haemostasis potential (OHP) assay with overall coagulation potential (OCP) and overall fibrinolytic potential (OFP) as supplementary parameters were measured by repeated fibrin formation and degradation registration.Results
In patients increased endogenous thrombin potential (4205 ± 440 nM x min vs 4015 ± 421 nM x min, p = 0.017), increased OCP (22.6 ± 4.6 Abs-sum vs 20.8 ± 4.1 Abs-sum, p = 0.025), shorter APTT (30.9 ± 3.8 s vs 33.4 ± 3.6 s, p < 0.001) and lower antithrombin activity (99, 93-105% vs 104, 100-109%, p < 0.05) were observed. Thrombophilia was observed in 22/60 (36%) patients and in 5/63 (7.9%, p < 0.001) controls. The only significant difference between thrombophilic and non-thrombophilic patients was higher soluble P-selectin in the former subgroup (22, 20-33 μg/L vs 17, 12-22 μg/L, p = 0.012).Conclusions
In women with a history of OC-related VT persistent hypercoagulability was observed, which, however was not augmented by the presence of thrombophilia. 相似文献994.
Takeshi Wada Satoshi Gando Asumi Mizugaki Yuichiro Yanagida Subrina Jesmin Hiroyuki Yokota Masahiro Ieko 《Thrombosis research》2013
Introduction
Post-cardiac arrest syndrome (PCAS) is often associated with disseminated intravascular coagulation (DIC), thus leading to the development of multiple organ dysfunction syndrome (MODS). The aim of this study was to examine the pathophysiological relationships between coagulation, fibrinolysis and fibrinolytic shutdown by evaluating the levels of coagulofibrinolytic markers, including soluble fibrin, thrombin-activatable fibrinolysis inhibitor (TAFI), tissue plasminogen activator-plasminogen activator inhibitor-1 complex (tPAIC), plasmin-alpha2 plasmin inhibitor complex (PPIC), neutrophil elastase and fibrin degradation product by neutrophil elastase (EXDP).Materials and Methods
Fifty-two resuscitated patients were divided into two groups: 22 DIC and 30 non-DIC patients.Results
The levels of soluble fibrin, PPIC, tPAIC, EXDP and neutrophil elastase in the DIC patients with PCAS were significantly higher than those observed in the non-DIC patients. The values of the tPAIC and JAAM DIC scores were found to be independent predictors of increased SOFA scores in the DIC patients. The MODS patients demonstrated significantly higher levels of soluble fibrin and tPAIC; however, the levels of TAFI and EXDP were identical between the patients with and without MODS. In addition, positive correlations were observed between the levels of tPAIC and EXDP in the patients with non-MODS; however, no correlations were observed between these markers in the MODS patients.Conclusions
Thrombin activation and fibrinolytic shutdown play important roles in the development of organ dysfunction in PCAS patients. Neutrophil elastase-mediated fibrinolysis cannot overcome the fibrinolytic shutdown that occurs in DIC patients with PCAS, thus resulting in the development of MODS. 相似文献995.
目的 探讨烟雾病(MMD)患者血清基质金属蛋白酶-9(MMP-9)和组织基质金属蛋白酶抑制剂-1(TIMP-1)的表达以及与颅内出血的关系.方法 检测26例有颅内出血的MMD的患者(出血组)、21例无出血的MMD患者(无出血组)及25名健康对照者(正常对照组)的血清MMP-9、TIMP-1水平,并进行比较.结果 与正常对照组比较,出血组与无出血组患者血清MMP-9及TIMP-1水平显著升高(均P<0.01).与无出血组比较,出血组MMP-9/TIMP-1显著增高(P<0.05),MMP-9与TIMP-1水平差异无统计学意义.出血组及无出血组血清TIMP-1与MMP-9水平均呈正相关(r=0.626,r=0.645;均P<0.01).结论 MMP-9及TIMP-1在MMD患者血清中表达显著升高.MMP-9与TIMP-1比例失衡可能是引起MMD患者颅内出血的重要机制. 相似文献
996.
Svetlana Zonis Vladimir A. Ljubimov Michael Mahgerefteh Robert N. Pechnick Kolja Wawrowsky Vera Chesnokova 《Hippocampus》2013,23(12):1383-1394
Altered neurogenesis in adult hippocampus is implicated in cognition impairment and depression. Inflammation is a potent inhibitor of neurogenesis. The cyclin‐dependent kinase inhibitor p21Cip1 (p21) restrains cell cycle progression and arrests the cell in the G1 phase. We recently showed that p21 is expressed in neuronal progenitors and regulates proliferation of these cells in the subgranular zone of the dentate gyrus of hippocampus where adult neurogenesis occurs. The current study suggests that p21 is induced in vivo in the hippocampus of WT mice in response to acute systemic inflammation caused by LPS injections, restrains neuronal progenitor proliferation and protects these cells from inflammation‐induced apoptosis. In intact p21?/? hippocampus, neuronal progenitors proliferate more actively as assessed by BrdU incorporation, and give rise to increased number of DCX positive neuroblasts. However, when mice were treated with LPS, the number of neuroblasts decreased due to induced subgranular zone apoptosis. In vitro, differentiating Tuj‐1 positive neuroblasts isolated from p21?/? hippocampus exhibited increased proliferation rate, measured by Ki‐67 staining, as compared to WT cells (p<0.05). In WT neuronal progenitors treated with IL‐6, the number of p21‐positive cells was increased (p<0.05), and this led to Tuj‐1+ cell proliferation restraint, whereas the number of proliferating GFAP+ astrocytes was increased ~ 2‐fold. Thus, when p21 is intact, inflammation might divert neuronal progenitors towards astrogliogenesis by inducing p21. At the same time, when p21 is lacking, no effects of IL‐6 on proliferation of Tuj‐1+ cells or GFAP+ cells are detected in differentiating p21?/? neuronal progenitors. These results underscore the important role of p21 controlling hippocampal neuronal differentiation during inflammation. © 2013 Wiley Periodicals, Inc. 相似文献
997.
Expression patterns and potential roles of SIRT1 in human medulloblastoma cells in vivo and in vitro
Jing‐Xin Ma Hong Li Xiao‐Ming Chen Xiang‐Hong Yang Qian Wang Mo‐Li Wu Qing‐You Kong Zai‐Xia Li Jia Liu 《Neuropathology》2013,33(1):7-16
Medulloblastoma is a primitive neuroectodermal tumor, which originates in the cerebellum, presumably due to the alterations of some neurogenetic elements. Sirtuin 1 (SIRT1), a class III histone deacetylase (HDAC), regulates differentiation of neuronal stem cells but its status in medulloblastomas remains largely unknown. The current study aimed to address this issue by checking SIRT1 expression in noncancerous cerebellar tissues, medulloblastoma tissues and established cell lines. The roles of SIRT1 in proliferation and survival of UW228‐3 medulloblastoma cells were analyzed by SIRT1 small interfering RNA (siRNA) transfection and SIRT1 inhibitor nicotinamide treatment. The results revealed that the frequency of SIRT1 expression in medulloblastoma tissues was 64.17% (77/120), while only one out of seven tumor‐surrounding noncancerous cerebellar tissues showed restricted SIRT1 expression in the cells within the granule layer. Of the three morphological subtypes, the rates of SIRT1 detection in the large cell/anaplastic cell (79.07%; 34/43) and the classic medulloblastomas (60.29%; 41/68) are higher than that (22.22%; 2/9) in nodular/desmoplastic medulloblastomas (P < 0.01 and P < 0.05, respectively). Heterogeneous SIRT1 expression was commonly observed in classic medulloblastoma. Inhibition of SIRT1 expression by siRNA arrested 64.96% of UW228‐3 medulloblastoma cells in the gap 1 (G1) phase and induced 14.53% of cells to apoptosis at the 48‐h time point. Similarly, inhibition of SIRT1 enzymatic activity with nicotinamide brought about G1 arrest and apoptosis in a dose‐related fashion. Our data thus indicate: (i) that SIRT1 may act as a G1‐phase promoter and a survival factor in medulloblastoma cells; and (ii) that SIRT1 expression is correlated with the formation and prognosis of human medulloblastomas. In this context, SIRT1 would be a potential therapeutic target of medulloblastomas. 相似文献
998.
999.
Cormac Magee David Graham Catherine Leonard Jessica McMaster Heather Davies Maria Skotchko 《Current medical research and opinion》2020,36(6):977-983
AbstractObjective: This economic evaluation aims to provide a preliminary assessment of the cost-effectiveness of radiofrequency ablation (RFA) compared with argon plasma coagulation (APC) when used to treat APC-refractory gastric antral vascular ectasia (GAVE) in symptomatic patients.Methods: A Markov model was constructed to undertake a cost-utility analysis for adults with persistent symptoms secondary to GAVE refractory to first line endoscopic therapy. The economic evaluation was conducted from a UK NHS and personal social services (PSS) perspective, with a 20-year time horizon, comparing RFA with APC. Patients transfer between health states defined by haemoglobin level. The clinical effectiveness data were sourced from expert opinion, resource use and costs were reflective of the UK NHS and benefits were quantified using Quality Adjusted Life Years (QALYs) with utility weights taken from the literature. The primary output was the Incremental Cost-Effectiveness Ratio (ICER), expressed as cost per QALY gained.Results: Over a lifetime time horizon, the base case ICER was £4840 per QALY gained with an 82.2% chance that RFA was cost-effective at a threshold of £20,000 per QALY gained. The model estimated that implementing RFA would result in reductions in the need for intravenous iron, endoscopic intervention and requirement for blood transfusions by 27.1%, 32.3% and 36.5% respectively. Compared to APC, RFA was associated with an estimated 36.7% fewer procedures.Conclusions: RFA treatment is likely to be cost-effective for patients with ongoing symptoms following failure of first line therapy with APC and could lead to substantive reductions in health care resource. 相似文献
1000.
Iman Mahlooji Maryam Shokri Rana Manoochehri Mohammad Mahboubi-Rabbani Elham Rezaee Sayyed Abbas Tabatabai 《Archiv der Pharmazie》2020,353(8):2000052
Soluble epoxide hydrolase (sEH) inhibitors are effective in reducing blood pressure, inflammation, and pain in a number of mammalian disease models. As most classical urea-based sEH inhibitors suffer from poor solubility and pharmacokinetic properties, the development of novel sEH inhibitors with an improved pharmacokinetic specification has received a great deal of attention. In this study, a series of amide-based sEH inhibitors bearing a phthalimide ring as the novel secondary pharmacophore (P2) was designed, synthesized, and evaluated. Docking results illustrated that the amide group as the primary pharmacophore (P1) was placed at a suitable distance from the three key amino acids (Tyr383, Tyr466, and Asp335) for an effective hydrogen bonding. In agreement with these findings, most of the newly synthesized compounds demonstrated moderate to high sEH inhibitory activities, relative to 12-(3-adamantan-1-yl-ureido)dodecanoic acid as the reference standard. Compound 12e with a 4-methoxybenzoyl substituent exhibited the highest sEH inhibitory activity, with an IC50 value of 1.06 nM. Moreover, the ADME properties of the compounds were evaluated in silico, and the results revealed appropriate predictions. 相似文献